(redirected from Consensus Interferon)
CIFNConsensus Interferon (molecular biology)
CIFNComplexo Industrial Ford Nordeste (Portuguese: Ford Industrial Complex Northeast; Ford Motor Co.; Brazil)
CIFNCentral Interior First Nations (Canada)
CIFNCentral Illinois Fire Network (Altamont, IL)
CIFNChemotherapy-Induced Fever and Neutropenia (pharmacotherapy)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
On-column refolding of consensus interferon at high concentration with guanidine-hydrochloride and polyethylene glycol gradients.
Kaiser, "Thyroid disorders and occurrence of Nonorgan-Specific Auto antibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1)," Journal of Clinical Gastroenterology, vol.
Racial Differences in Response Rates to Consensus Interferon in HCV Infected Patients Naive to Previous Therapy.
Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial.
Consensus interferon (CIFN) is a recombinant type 1 IFN containing 166 amino acids.
Three Rivers markets several products for hepatitis C, including Infergen (Consensus Interferon), Ribasphere (ribavirin, USP) and RibaPak (ribavirin).
He said after new research findings there is a new ray of hope with newly launched Consensus Interferon (Infergen).
The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon. Journal of Interferon Cytokine Research, 16(7), 489-499.
[4.] Bonkovsky H.L., Woolley J.M., the Consensus Interferon Study Group.
Newer therapies of HCV have also been discussed namely oral interferon inducers, immunomodulating drugs, newer interferons such as consensus interferon and albuferon.
The investigator-initiated study, conducted by researchers from the University of Tubingen in Germany, showed that at the end of 72 weeks of daily therapy, the majority of patients treated with a combination of either consensus interferon plus ribavirin or pegylated interferon alfa-2a plus ribavirin had a reduction in hepatitis RNA.
The pegylated alfa-2a interferon combination had significantly higher rates of relapse than the consensus interferon combination.